Furthermore, decreased circulating levels of AnxA1 are present in thrombo-inflammatory conditions including ischaemic stroke, SCD, sepsis, Crohn’s disease, and obesity [29]. This evidence concerns the gene ANXA1 and Schnyder corneal dystrophy.